New ECF Open-Access Article on the Prognostic Implication of Delays in the Definitive Treatment of Uveal Melanoma Now Available!
November 14, 2024: On behalf of the Authors and Doctors, Gustav Stålhammar, Salvatore Grisanti and Paul T. Finger, this article was sponsored and supported by for open access publication by The Eye Cancer Foundation!
About the Article:
On the Prognostic Implication of Delays in the Definitive Treatment of Uveal Melanoma
Delays in treating intraocular melanoma, a type of eye cancer, have been shown to increase the risk of the cancer spreading to other parts of the body, according to three distinct studies. Traditionally, small intraocular melanomas are often monitored for growth before treatment decisions are made. However, recent evidence from these studies suggests that prolonged observation of malignant choroidal melanomas may raise the likelihood of metastasis.
Research from Sweden, Germany, and a multicenter international registry have explored the relationship between treatment delays and the risk of cancer progression. These studies indicate that timely intervention can significantly reduce the risk of metastasis and improve survival rates. Delays in treatment have often been attributed to concerns about potential radiation-induced vision loss.
This article also reviews the side effects associated with current treatments, such as radiation therapy, and discusses emerging strategies and medications designed to help preserve vision following treatment. The findings emphasize the importance of timely, personalized treatment strategies to enhance both survival outcomes and quality of life for patients with intraocular melanoma.
To read the full article or download the paper, click here: https://www.mdpi.com/2072-6694/16/22/3834
About the Article:
On the Prognostic Implication of Delays in the Definitive Treatment of Uveal Melanoma
Delays in treating intraocular melanoma, a type of eye cancer, have been shown to increase the risk of the cancer spreading to other parts of the body, according to three distinct studies. Traditionally, small intraocular melanomas are often monitored for growth before treatment decisions are made. However, recent evidence from these studies suggests that prolonged observation of malignant choroidal melanomas may raise the likelihood of metastasis.
Research from Sweden, Germany, and a multicenter international registry have explored the relationship between treatment delays and the risk of cancer progression. These studies indicate that timely intervention can significantly reduce the risk of metastasis and improve survival rates. Delays in treatment have often been attributed to concerns about potential radiation-induced vision loss.
This article also reviews the side effects associated with current treatments, such as radiation therapy, and discusses emerging strategies and medications designed to help preserve vision following treatment. The findings emphasize the importance of timely, personalized treatment strategies to enhance both survival outcomes and quality of life for patients with intraocular melanoma.
To read the full article or download the paper, click here: https://www.mdpi.com/2072-6694/16/22/3834
